-
Mashup Score: 1
Oral and Poster Abstracts 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III Biological therapies, Therapies, Immunotherapy Lucia Masarova, MD1, Prithviraj Bose, MD2, Naveen Pemmaraju, MD1, Mary Ann Richie1*, Gautam Borthakur, MD1, Zeev E. Estrov, MD1, Hagop Kantarjian, MD3, Keyur P. Patel, MBBS, PhD4 and Srdan Verstovsek, MD,…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 7
Loss of the dNTPase and DNA repair enzyme SAMHD1 is associated with cancer and causes systemic autoimmunity. We show transformation-promoting spontaneous DNA da
Source: Rockefeller University PressCategories: General Medicine News, Latest HeadlinesTweet-
Viral #RNA sequences in our genetic information lead to #interferon-driven autoimmunity @JExpMed https://t.co/XedAh5J1C9 https://t.co/4ROdLwfxtF
-
-
Mashup Score: 9Please wait whilst we redirect you - 2 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2022 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists1Tweet-
Incredible and historical review @CellCellPress on JAK-STAT signaling from the #interferon pioneers, James Darnell, John O’Shea and George Stark @CCLRI @CleClinicMD https://t.co/mUzhlRfHVb https://t.co/91A0LfXCGG
-
-
Mashup Score: 19Eiger BioPharmaceuticals Provides Update on Plans for Emergency Use Authorization Application Following FDA Feedback | Eiger BioPharmaceuticals - 2 year(s) ago
The Investor Relations website contains information about Eiger BioPharmaceuticals’s business for stockholders, potential investors, and financial analysts.
Source: Eiger BioPharmaceuticalsCategories: Infectious Disease, Latest HeadlinesTweet-
I want to thank the @US_FDA for keeping Americans safe by holidng the line against #COVID19 therapeutics that have shown benefit in double-blind randomized trials in a majority vaccinated population. (#interferon-lambda). https://t.co/rfFmuv4eEt
-
-
Mashup Score: 0Wyss researchers discover a new type of RNA that inhibits a broad range of viral infections - 2 year(s) ago
Novel immunostimulatory dsRNAs activate antiviral responses against multiple pandemic viruses in mouse and human organ chip models
Source: Wyss InstituteCategories: Healthcare Professionals, Latest HeadlinesTweet-
Wyss researchers discover a new type of #RNA that inhibits a #broadspectrum of #viralinfections https://t.co/nCU9WQPce9 via @wyssinstitute #IFN #Interferon Novel #selfassembly immunostimulatory #dsRNAs activate #antiviral responses against multiple pandemic #respiratoryviruses
-
-
Mashup Score: 14Emerging concepts of type I interferons in SLE pathogenesis and therapy - Nature Reviews Rheumatology - 2 year(s) ago
In this Review, Psarras, Wittmann and Vital discuss evidence of the production of type I interferons by cells and tissues other than haematopoietic cells. These interferons can have local effects, and their roles in the pathogenesis of systemic lupus erythematosus suggest the value of interferon-blocking therapies for treatment of this condition.
Source: NatureCategories: Latest Headlines, RheumatologyTweet-
Online now! @AntonyPsarras, Miriam Wittmann & @edvital discuss production of type I #interferon by non-haematopoietic cells and its role in the pathogenesis of #SLE https://t.co/Z7qN7ucuN5 https://t.co/seF1fNDMtm
-
-
Mashup Score: 1
MONTEREY, Calif. — Interferon alpha-2b, 5-fluorouracil and mitomycin C can all be used topically for conjunctival tumors, Lauren A. Dalvin, MD, said at the Women in Ophthalmology Summer Symposium.“Compared to surgical therapy, these do require more time; these do require reliable patient follow-up,” Dalvin said.
Source: www.healio.comCategories: Latest Headlines, OphthalmologyTweet-
Topical medications for #ConjunctivalTumors have pluses and minuses. https://t.co/ilr9EcDqRe @LADalvinMD @MayoClinicEye @WIO_WomenInOpht #WIO2022 #WomeninOphthalmologySummerSymposium #Interferon #mitomycin
-
-
Mashup Score: 1Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer - 2 year(s) ago
Controlling lysophosphatidic acid production in the tumor microenvironment sensitizes ovarian cancer cells to various forms of immunotherapy by unleashing protective type I interferon responses.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
From the August issue: Tumor-derived Lysophosphatidic Acid Blunts Protective Type-I #Interferon Responses in #OvarianCancer, by Chae, @JCubRuiz et al. https://t.co/IGhxdZkM8r @WeillCornell #immunotherapy https://t.co/WZpX3lqnn0
-
-
Mashup Score: 5
Genetic and functional studies implicate allele-specific regulation of OAS1 splicing and nonsense-mediated decay in COVID-19 severity. The OAS1 risk haplotype is also associated with reduced SARS-CoV-2 clearance in a clinical trial with pegIFN-λ1.
Source: NatureCategories: General Medicine News, Latest HeadlinesTweet-
#Interferon treatment may reduce severity of COVID-19 in people with certain #geneticfactors @NIHforHealth @NatureGenet https://t.co/ktRSstq0kH https://t.co/XqK5GoJ3iB
-
-
Mashup Score: 0Epigenetic activation of antiviral sensors and effectors of interferon response pathways during SARS-CoV-2 infection - 2 year(s) ago
Recent studies have shown that methylation changes identified in blood cells of COVID-19 patients have a potential to be used as biomarkers of SARS-Co…
Source: www.sciencedirect.comCategories: Future of Medicine, Latest HeadlinesTweet-
Collaboration to show that #COVID19 SARS-CoV-2 #infection induces #epigenetic activation of antiviral sensors and #interferon response, study led by Tomasz K. Wojdacz @AarhusUni @pumszczecin in Biomedicine & Pharmacotherapy @sciencedirect https://t.co/TjPH0ggcKf https://t.co/r1YkDsa9pV
-
#ASH22 | Dr Lucia Masarova @MDmasarova will present our group’s long-term results of pegylated #interferon in patients with ET & PV with median f/u now of *15 years* | #MPNSM https://t.co/7tPPY3Y9kb | #SergeVerstovsek @MDAndersonNews #endcancer @ASH_hematology https://t.co/ro9F4pfcaa